Unknown

Dataset Information

0

Oxytocin attenuates microglial activation and restores social and non-social memory in APP/PS1 Alzheimer model mice.

ABSTRACT: Alzheimer's disease (AD) is characterized by neurodegeneration, memory loss, and social withdrawal. Brain inflammation has emerged as a key pathogenic mechanism in AD. We hypothesized that oxytocin, a pro-social hypothalamic neuropeptide with anti-inflammatory properties, could have therapeutic actions in AD. Here, we investigated oxytocin expression in experimental models of AD, and evaluated the therapeutic potential of treatment with oxytocin. Amyloid-β peptide oligomers (AβOs) reduced oxytocin expression in vitro and in vivo, and treatment with oxytocin prevented microglial activation induced by AβOs in purified microglial cultures. Treatment of aged APP/PS1 mice, a mouse model of AD, with intranasal oxytocin attenuated microglial activation and favored deposition of Aβ in dense core plaques, a potentially neuroprotective mechanism. Remarkably, treatment with oxytocin alleviated social and non-social memory impairments in aged APP/PS1 mice. Our findings point to oxytocin as a potential therapeutic target to reduce brain inflammation and correct memory deficits in AD.

SUBMITTER: Selles MC 

PROVIDER: S-EPMC10148027 | biostudies-literature | 2023 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Oxytocin attenuates microglial activation and restores social and non-social memory in APP/PS1 Alzheimer model mice.

Selles Maria Clara MC   Fortuna Juliana T S JTS   de Faria Yasmin P R YPR   Siqueira Luciana Domett LD   Lima-Filho Ricardo R   Longo Beatriz M BM   Froemke Robert C RC   Chao Moses V MV   Ferreira Sergio T ST  

iScience 20230331 4

Alzheimer's disease (AD) is characterized by neurodegeneration, memory loss, and social withdrawal. Brain inflammation has emerged as a key pathogenic mechanism in AD. We hypothesized that oxytocin, a pro-social hypothalamic neuropeptide with anti-inflammatory properties, could have therapeutic actions in AD. Here, we investigated oxytocin expression in experimental models of AD, and evaluated the therapeutic potential of treatment with oxytocin. Amyloid-β peptide oligomers (AβOs) reduced oxytoc  ...[more]

Similar Datasets

Unknown Exogenous Oxytocin Administration Restores Memory in Female APP/PS1 Mice.
| S-EPMC10741313 | biostudies-literature
Unknown Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice.
| S-EPMC6417212 | biostudies-literature
Unknown Apicidin attenuates memory deficits by reducing the Aβ load in APP/PS1 mice.
| S-EPMC10068467 | biostudies-literature
Unknown Intraperitoneal injection of IFN-γ restores microglial autophagy, promotes amyloid-β clearance and improves cognition in APP/PS1 mice.
| S-EPMC7280212 | biostudies-literature
Unknown LongShengZhi Capsule Attenuates Alzheimer-Like Pathology in APP/PS1 Double Transgenic Mice by Reducing Neuronal Oxidative Stress and Inflammation.
| S-EPMC7719723 | biostudies-literature
Unknown Minor ginsenoside F1 improves memory in APP/PS1 mice.
| S-EPMC6728944 | biostudies-literature
Unknown Overexpression of LIMK1 in hippocampal excitatory neurons improves synaptic plasticity and social recognition memory in APP/PS1 mice.
| S-EPMC8314529 | biostudies-literature
Unknown The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
| S-EPMC4791593 | biostudies-literature
Unknown CART treatment improves memory and synaptic structure in APP/PS1 mice.
| S-EPMC4426675 | biostudies-literature
Unknown Hippocampal CysLT1R overexpression or activation accelerates memory deficits, synaptic dysfunction, and amyloidogenesis in young APP/PS1 transgenic mice.
| S-EPMC8576703 | biostudies-literature